Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
kombineeritud ravi teiste haigust modifitseerivate ravimitega.
combination with other dmts.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
peamised resistentsusmehhanismid on ravimi bakterirakust väljapumpamine ja ravimi inaktiveerimine modifitseerivate ensüümide poolt.
the main resistance mechanisms are drug efflux and drug inactivation by modifying enzymes.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
teiste haigust modifitseerivate antireumaatiliste ravimite (dmardid) samaaegne/järjestikune kasutamine reumatoidartriidi korral
concomitant/sequential use of other dmards in rheumatoid arthritis
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
aktiivse ja progresseeruva psoriaatilise artriidi ravi täiskasvanutel, kellel ravi haiguse kulgu modifitseerivate reumavastaste ravimitega ei ole olnud piisav.
treatment of active and progressive psoriatic arthritis in adults when the response to previous disease- modifying antirheumatic drug therapy has been inadequate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
enbreli pikaajalist ohutust kombinatsioonis teiste haiguse kulgu modifitseerivate reumavastaste ravimitega (hmr) ei ole kindlaks tehtud.
the long-term safety of enbrel in combination with other disease-modifying antirheumatic drugs (dmard) has not been established.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
samuti olid patsientidel ägedad psoriaatilised nahakahjustused või anamneesis psoriaas ning 1 või kaks korda nurjunud ravi haigust modifitseerivate antireumaatilistega ravimitega (dmards).
patients also had active psoriatic skin lesions or a documented history of psoriasis and had failed 1 or more dmards.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
79 (20,1%) patsienti raviti samaaegselt haigust modifitseerivate antireumaatiliste ainetega ja 37 (9,4%) patsienti glükokortikoididega.
seventy-nine (20.1%) patients were treated concomitantly with disease modifying anti − rheumatic drugs, and 37 (9.4%) patients with glucocorticoids.
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
tysabrit ei tohi manustada koos teiste haigust modifitseerivate ravimitega, seda ei tohi kasutada vähipatsiendid (v.a basaalrakuliseks kartsinoomiks nimetatava nahavähiga patsiendid) ega alla 18-aastased.
it must not be given in combination with other disease-modifying medicines, to patients who have cancer (unless it is a type of skin cancer called basal cell carcinoma) or to patients who are under 18 years of age.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
teiste haigust modifitseerivate antireumaatiliste ravimite (dmardid) samaaegne/ järjestikune kasutamine mabthera’ t ei soovitata kasutada koos teiste antireumaatiliste ravimitega peale nende, mis on loetletud reumatoidartriidi näidustuse ja annustamise all.
35 concomitant/ sequential use of other dmards the concomitant use of mabthera and antirheumatic therapies other than those specified under the rheumatoid arthritis indication and posology is not recommended.
Last Update: 2012-04-11
Usage Frequency: 4
Quality: